Growth Metrics

Mesoblast (MESO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $84.6 million.

  • Mesoblast's Total Non-Current Liabilities fell 2677.51% to $84.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $84.6 million, marking a year-over-year decrease of 2677.51%. This contributed to the annual value of $84.6 million for FY2025, which is 2677.51% down from last year.
  • Latest data reveals that Mesoblast reported Total Non-Current Liabilities of $84.6 million as of Q2 2025, which was down 2677.51% from $119.3 million recorded in Q4 2024.
  • Over the past 5 years, Mesoblast's Total Non-Current Liabilities peaked at $130.2 million during Q4 2023, and registered a low of $66.6 million during Q1 2021.
  • Over the past 5 years, Mesoblast's median Total Non-Current Liabilities value was $113.2 million (recorded in 2022), while the average stood at $104.1 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 3419.85% in 2021, then skyrocketed by 6860.87% in 2022.
  • Quarter analysis of 5 years shows Mesoblast's Total Non-Current Liabilities stood at $111.0 million in 2021, then rose by 2.26% to $113.5 million in 2022, then increased by 14.72% to $130.2 million in 2023, then decreased by 8.36% to $119.3 million in 2024, then fell by 29.08% to $84.6 million in 2025.
  • Its last three reported values are $84.6 million in Q2 2025, $119.3 million for Q4 2024, and $115.6 million during Q2 2024.